Serum semaphorin 4C as a diagnostic biomarker in breast cancer: A multicenter retrospective study

BACKGROUND: To date, there is no approved blood‐based biomarker for breast cancer detection. Herein, we aimed to assess semaphorin 4C (SEMA4C), a pivotal protein involved in breast cancer progression, as a serum diagnostic biomarker. METHODS: We included 6,213 consecutive inpatients from Tongji Hosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ya, Qiao, Long, Yang, Jie, Li, Xiong, Duan, Yaqi, Liu, Jiahao, Chen, Shaoqi, Li, Huayi, Liu, Dan, Fang, Tian, Ma, Jingjing, Li, Xiaoting, Ye, Fei, Wan, Junxiang, Wei, Juncheng, Xu, Qin, Guo, Ensong, Jin, Ping, Wu, Mingfu, Zhang, Lin, Xia, Yun, Wu, Yaqun, Shao, Jun, Feng, Yaojun, Zhang, Qing, Yang, Zongyuan, Chen, Gang, Zhang, Qinghua, Li, Xingrui, Wang, Shixuan, Hu, Junbo, Wang, Xiaoyun, Tan, Mona P., Takabe, Kazuaki, Kong, Beihua, Yang, Qifeng, Ma, Ding, Gao, Qinglei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8696225/
https://www.ncbi.nlm.nih.gov/pubmed/34738326
http://dx.doi.org/10.1002/cac2.12233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8696225/
https://www.ncbi.nlm.nih.gov/pubmed/34738326
http://dx.doi.org/10.1002/cac2.12233

Ejemplares similares